Catalyst Pharmaceutical Partners Inc buy Truist Financial Co.
Start price
09.08.24
/
50%
€16.68
Target price
09.08.25
€27.48
Performance (%)
9.83%
Price
12.09.24
€18.32
Summary
This prediction is currently active. With a performance of 9.83%, the BUY prediction by Truist_Financial_Co_ for Catalyst Pharmaceutical Partners Inc is trending in the right direction. This prediction currently runs until 09.08.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Catalyst Pharmaceutical Partners Inc | 1.891% | 1.891% |
iShares Core DAX® | 2.275% | 4.627% |
iShares Nasdaq 100 | 6.015% | 2.007% |
iShares Nikkei 225® | 4.456% | 3.598% |
iShares S&P 500 | 4.061% | 2.876% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at Truist Financial Co. from $25.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for CPRX provided by MarketBeat